Abstract
Viral infection in animals and plants is a serious problem worldwide. It causes dramatic losses in health and economy. Many approaches to combat with viral infectious diseases have been intensively investigated. Measures taken against viral infections can either aim for protecting from viral infection or eliminating the viruses after infection. RNA dependent RNA polymerase (RdRp) is a key enzyme for viral replication and found in all positive strand RNA viruses. Disturbing the RdRp activity therefore results in reducing or inhibiting the virus infection. In this review we focus on reviewing different strategies and agents to inhibit the RdRps of different mammalian and plant positive-sense (ss) RNA viruses. The strategies described in this review are mainly focusing on interference of the nucleotides which are the substrates need for RdRp and blocking the RdRp itself by using chemical agents or antibodies specifically binding to the different domains of the RdRps. Moreover using small interfering (si) RNA technology platform to inhibit the RdRp activity is also discussed.
Current Enzyme Inhibition
Title: Inhibitions of Positive-Sense (ss) RNA Viruses RNA-Dependent RNA Polymerases
Volume: 5 Issue: 4
Author(s): Kajohn Boonrod and Gabriele Krczal
Affiliation:
Abstract: Viral infection in animals and plants is a serious problem worldwide. It causes dramatic losses in health and economy. Many approaches to combat with viral infectious diseases have been intensively investigated. Measures taken against viral infections can either aim for protecting from viral infection or eliminating the viruses after infection. RNA dependent RNA polymerase (RdRp) is a key enzyme for viral replication and found in all positive strand RNA viruses. Disturbing the RdRp activity therefore results in reducing or inhibiting the virus infection. In this review we focus on reviewing different strategies and agents to inhibit the RdRps of different mammalian and plant positive-sense (ss) RNA viruses. The strategies described in this review are mainly focusing on interference of the nucleotides which are the substrates need for RdRp and blocking the RdRp itself by using chemical agents or antibodies specifically binding to the different domains of the RdRps. Moreover using small interfering (si) RNA technology platform to inhibit the RdRp activity is also discussed.
Export Options
About this article
Cite this article as:
Boonrod Kajohn and Krczal Gabriele, Inhibitions of Positive-Sense (ss) RNA Viruses RNA-Dependent RNA Polymerases, Current Enzyme Inhibition 2009; 5 (4) . https://dx.doi.org/10.2174/157340809789630262
DOI https://dx.doi.org/10.2174/157340809789630262 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Opiate Drug Use and the Pathophysiology of NeuroAIDS
Current HIV Research 3D Modeling of Dengue Virus NS4B and Chikungunya Virus nsP4: Identification of a Common Drug Target and Designing a Single Antiviral Inhibitor
Current Computer-Aided Drug Design Multiple Roles for Chemokines in the Pathogenesis of SIV Infection
Current HIV Research Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research Intrinsic Disorder and Function of the HIV-1 Tat Protein
Protein & Peptide Letters The Role of Inflammation in Epilepsy
Current Pediatric Reviews Antiviral Immunotherapy for Mosquito-Borne Flaviviruses: A Review of Current Status
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Current Gene Therapy Recent Developments in Delivery of Nucleic Acid-Based Antiviral Agents
Current Pharmaceutical Design Developments in High-Yield System Expressed Vaccines and Immunotherapy
Recent Patents on Biotechnology New Drug Targets for Hepatitis C and Other Flaviviridae Viruses
Infectious Disorders - Drug Targets Designing Immunogens to Elicit Broadly Neutralizing Antibodies to the HIV-1 Envelope Glycoprotein
Current HIV Research Genomic Databases and the Search of Protein Targets for Protozoan Parasites
Current Drug Targets The Effects of Psychopharmacologic and Therapeutic Approaches on Neuro-imaging in Obsessive-compulsive Disorder
Current Neuropharmacology Nucleic Acid-Based Therapeutics for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Progressive Supranuclear Palsy: What Do We Know About it?
Current Medicinal Chemistry Multiple Roles of the Extracellular Matrix in Inflammation
Current Pharmaceutical Design Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Current Alzheimer Research Mechanisms Governing Lentivirus Integration Site Selection
Current Gene Therapy